Nurse Practitioner Program year 2022 Reported 2021–2022 Source: CMS Open Payments, 2026 publication

Jenessa McKray

Registered Nurse, Wound Care Frisco, TX Nurse Practitioner

NPI 1548631195 CMS profile 11102742

8350 Dallas Pkwy, Frisco, TX 75034

Open in the dashboard

General payments

$691

21 records reported · program years 2021–2022

Research payments

$0

Paid to them · None reported · program years 2021–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Jenessa McKray of Frisco, TX is reported in the CMS Open Payments database as having received $691 across 21 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $56 2
2021 General $635 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jenessa McKray
  • Registered Nurse, Wound Care median
  • Middle half of Registered Nurse, Wound Care
  • National median

In program year 2025, general payments to Jenessa McKray were reported at $0. Among 20 Registered Nurse, Wound Care profiles paid that year, the median was $137 and the middle half received between $77 and $249.

Show as a table
Year Jenessa McKray Registered Nurse, Wound Care median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $635 — — $132
2022 $56 — — $149
2023 $0 — — $160
2024 $0 — — $164
2025 $0 $137 $77–$249 $169

Breakdown

Who paid General payments · program years 2021–2022
  1. Abbott Laboratories $553 15 payments
  2. Integra LifeSciences Corporation $55 2 payments
  3. Orthofix Medical, Inc. $39 1 payment
  4. Medtronic, Inc. $26 2 payments
  5. Baudax Bio Inc. $19 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2022
  1. Food and Beverage $691 21 payments
Products named General payments · program years 2021–2022
  1. Penta SCS Leads $199 4 payments
  2. Octrode SCS Leads $138 5 payments
  3. Proclaim IPG $83 3 payments
  4. Proclaim DRG IPG $77 1 payment
  5. PROCLAIM $56 2 payments
  6. CODMAN CERTAS $55 2 payments
  7. CUSA CLARITY $55 2 payments
  8. DURASEAL EXACT SPINAL SEALANT SYSTEM $55 2 payments
  9. DURAGEN DURAL GRAFT MATRIX $55 2 payments
  10. HAKIM $55 2 payments
  11. Other $45 3 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 20 billing codes

Paid by Medicare

$3,102

Medicare's payments for the services billed

Medicare patients

26

Average age 82

Services billed

146

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 73%
Chronic kidney disease 54%
Ischemic heart disease 46%
Atrial fibrillation 46%
Alzheimer's or dementia 42%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

21 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Registered Nurse, Wound Care in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record